PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E8.43 EPS (ttm)5.19 Insider Own0.05% Shs Outstand5.61B Perf Week-0.73%
Market Cap248.33B Forward P/E8.32 EPS next Y5.26 Insider Trans-5.25% Shs Float5.61B Perf Month-3.25%
Income29.75B PEG1.56 EPS next Q1.50 Inst Own70.40% Short Float1.14% Perf Quarter-16.34%
Sales101.13B P/S2.46 EPS this Y233.60% Inst Trans1.88% Short Ratio3.59 Perf Half Y-15.47%
Book/sh15.59 P/B2.81 EPS next Y-18.86% ROA15.80% Target Price56.81 Perf Year1.74%
Cash/sh5.87 P/C7.46 EPS next 5Y5.40% ROE36.30% 52W Range40.94 - 61.71 Perf YTD-25.89%
Dividend1.60 P/FCF12.68 EPS past 5Y27.40% ROI18.90% 52W High-29.09% Beta0.68
Dividend %3.66% Quick Ratio1.20 Sales past 5Y9.00% Gross Margin62.20% 52W Low6.89% ATR0.93
Employees79000 Current Ratio1.40 Sales Q/Q46.80% Oper. Margin33.80% RSI (14)34.67 Volatility1.66% 2.11%
OptionableYes Debt/Eq0.46 EPS Q/Q69.20% Profit Margin29.00% Rel Volume1.29 Prev Close44.16
ShortableYes LT Debt/Eq0.39 EarningsJul 28 BMO Payout30.20% Avg Volume17.80M Price43.76
Recom2.30 SMA20-3.88% SMA50-8.45% SMA200-14.26% Volume22,903,637 Change-0.91%
May-23-22Initiated SVB Leerink Mkt Perform $55
Apr-06-22Resumed Morgan Stanley Equal-Weight $55
Jan-05-22Upgrade BofA Securities Neutral → Buy $59 → $70
Jan-03-22Reiterated Bernstein Mkt Perform $44 → $65
Dec-20-21Reiterated Cowen Outperform $56 → $70
Dec-17-21Initiated Goldman Neutral $51
Dec-13-21Upgrade UBS Neutral → Buy $52 → $60
Dec-09-21Initiated Wells Fargo Overweight $60
Nov-19-21Initiated BMO Capital Markets Outperform $60
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Oct-01-22 10:37AM
Sep-30-22 01:04PM
09:10AM
09:00AM
Sep-29-22 05:55PM
12:00PM Loading…
12:00PM
11:58AM
08:39AM
07:16AM
07:00AM
Sep-28-22 11:50AM
09:00AM
07:15AM
12:00AM
Sep-27-22 12:46PM
12:51AM Loading…
12:51AM
Sep-26-22 05:45PM
04:42PM
02:21PM
12:39PM
09:05AM
09:03AM
07:52AM
07:30AM
07:13AM
07:03AM
06:54AM
06:45AM
06:35AM
Sep-25-22 07:00AM
04:50PM Loading…
Sep-24-22 04:50PM
04:19PM
07:00AM
Sep-23-22 04:08PM
12:02PM
11:02AM
10:51AM
10:48AM
09:10AM
08:40AM
Sep-22-22 05:55PM
04:15PM
10:37AM
08:11AM
08:00AM
06:51AM
06:45AM
06:45AM
06:20AM
Sep-21-22 11:15AM
07:00AM
06:18AM
Sep-20-22 07:24PM
05:45PM
03:27PM
03:13PM
11:08AM
10:14AM
10:05AM
10:00AM
09:53AM
09:06AM
05:31AM
05:29AM
02:37AM
02:17AM
02:17AM
Sep-19-22 11:52PM
12:21PM
11:46AM
11:31AM
09:31AM
08:14AM
06:45AM
05:23AM
Sep-17-22 02:34PM
Sep-16-22 06:12PM
01:41PM
10:39AM
09:00AM
08:37AM
Sep-15-22 08:21PM
06:43PM
06:35PM
04:27PM
02:45PM
02:35PM
11:54AM
10:56AM
09:27AM
08:40AM
07:02AM
06:45AM
Sep-14-22 05:45PM
04:11PM
03:16PM
01:23PM
10:15AM
10:00AM
09:14AM
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerJun 07Sale53.964,218227,60310,846Jun 08 04:43 PM
DAMICO JENNIFER B.SVP & ControllerMay 16Sale50.504,000202,00015,064May 17 07:48 AM
SAHNI PAYALExecutive Vice PresidentMay 13Sale49.841,40870,17517,372May 16 09:23 PM
Carapezzi William R JRExecutive Vice PresidentMay 12Sale50.0032,9081,645,40038,146May 13 05:38 PM
LANKLER DOUGLAS MExecutive Vice PresidentMay 12Sale49.4138,2731,891,06978,803May 13 05:19 PM
Dolsten MikaelPresident R&DMay 11Sale49.3263,9023,151,547333,342May 12 04:34 PM
Dolsten MikaelPresident R&DMar 03Option Exercise31.83102,4603,261,036396,578Mar 04 04:13 PM
DAMICO JENNIFER B.SVP & ControllerFeb 26Option Exercise25.609,713248,65326,120Mar 01 04:02 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 26Option Exercise25.6077,7091,989,350174,507Mar 01 04:03 PM
McDermott MichaelExecutive Vice PresidentFeb 26Option Exercise25.6012,340315,90483,530Mar 01 04:03 PM
Carapezzi William R JRExecutive Vice PresidentFeb 26Option Exercise25.6021,193542,54187,363Mar 01 04:03 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 26Option Exercise25.60127,1603,255,296649,918Mar 01 05:55 PM
SUSMAN SALLYExecutive Vice PresidentFeb 26Option Exercise25.6063,5801,627,648172,880Mar 01 05:55 PM
SAHNI PAYALExecutive Vice PresidentFeb 23Option Exercise27.3413,884379,58929,391Feb 25 06:27 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise27.3476,8952,102,309166,470Feb 25 06:29 PM
Hwang AngelaGroup PresidentFeb 23Option Exercise27.3421,359583,95521,359Feb 25 06:10 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise27.34115,3423,153,450181,659Feb 25 06:20 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise27.34153,7894,204,591636,977Feb 25 06:04 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise27.3435,457969,39491,301Feb 25 06:17 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23Option Exercise27.3411,748321,19021,668Feb 25 05:46 PM
Carapezzi William R JRExecutive Vice PresidentFeb 23Option Exercise27.3425,632700,77982,914Feb 25 05:06 PM
Dolsten MikaelPresident R&DDec 17Option Exercise30.1771,1872,147,712351,637Dec 21 06:31 PM
BOURLA ALBERTChairman & CEODec 17Option Exercise26.73123,0553,289,547246,444Dec 21 06:03 PM
JOHNSON RADY AExecutive Vice PresidentDec 03Sale53.4219,0001,015,04255,844Dec 06 05:18 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 02Sale54.2641,3602,244,19487,280Dec 06 05:18 PM
SUSMAN SALLYExecutive Vice PresidentNov 26Sale54.5244,3082,415,57889,575Nov 30 04:30 PM
LANKLER DOUGLAS MExecutive Vice PresidentNov 26Sale54.3740,0002,174,78666,317Nov 30 04:30 PM
Hwang AngelaGroup PresidentNov 12Sale49.6026,1701,298,0021Nov 15 05:32 PM
Dolsten MikaelPresident R&DNov 11Option Exercise25.13199,5485,014,926339,506Nov 15 05:40 PM
Dolsten MikaelPresident R&DNov 11Sale50.2959,6643,000,647279,842Nov 15 05:40 PM
YOUNG JOHN DGroup PresidentNov 11Sale50.06150,0007,508,732312,704Nov 12 06:08 PM